B · Normal
On October 22, the CXO sector of the Hong Kong stock market fell in the afternoon, with Zhaoyan New Drug falling by more than 10%, Asymchem falling by nearly 9%, WuXi Biologics, Tigermed, GenScript Biotech, and WuXi AppTec falling by more than 5%.
Comments